AHL
PRAX icon

Abel Hall LLC’s Praxis Precision Medicines PRAX Stock Holding History

Abel Hall LLC’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$341K Sell
1,019
-373
-27% -$118K 0.06% 412
2026
Q1 		$448K Buy
1,392
+360
+35% +$111K 0.1% 229
2025
Q4 		$304K Buy
+1,032
New +$192K 0.07% 327

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Abel Hall LLC's PRAX Position: Q2 2026 in Review

Abel Hall LLC reduced its Praxis Precision Medicines (PRAX) stake by 27% in Q2 2026, selling an estimated $118K and leaving 1,019 shares worth $341K. The position accounts for 0.06% of the portfolio, ranked #412.

Abel Hall LLC first reported a position in PRAX in Q4 2025 and has held it in 3 quarters since. The position peaked at $448K in Q1 2026. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Abel Hall LLC held 1,019 shares of Praxis Precision Medicines worth $341K as of Q2 2026.
  • Abel Hall LLC sold 373 Praxis Precision Medicines shares in Q2 2026, an estimated $118K.
  • Praxis Precision Medicines made up 0.06% of Abel Hall LLC's portfolio in Q2 2026, its #412 holding.
  • Abel Hall LLC first reported a position in Praxis Precision Medicines in Q4 2025 and has held it in 3 quarters since.
  • Abel Hall LLC's Praxis Precision Medicines position peaked at $448K in Q1 2026.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Abel Hall LLC's 13F filing for Q2 2026, filed 24 Jul 2026.